Skip to main navigation Skip to search Skip to main content

An Open-Label, Randomized, Adaptive, Multicenter, Pharmacokinetic/Pharmacodynamic, Phase 1B, Study of Oseltamivir (Tamiflu(R)) in the Treatment of Influenza in Immunocompromised Children, Between 0-18 Years of Age, with Confirmed Influenza

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date12/3/12 → 12/2/17

Funding

  • Genentech Incorporated: $6,980.15